Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History IRIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics IRIX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

IRIDEX Corporation

IRIX
Current price
1.26 USD -0.03 USD (-2.33%)
Last closed 1.07 USD
ISIN US4626841013
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 21 657 810 USD
Yield for 12 month -36.68 %
1Y
3Y
5Y
10Y
15Y
IRIX
21.11.2021 - 28.11.2021

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. Address: 1212 Terra Bella Avenue, Mountain View, CA, United States, 94043

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.00 USD

P/E Ratio

Dividend Yield

Financials IRIX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures IRIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+48 669 000 USD

Last Year

+51 869 000 USD

Current Quarter

+11 896 000 USD

Last Quarter

+12 696 000 USD

Current Year

+19 502 000 USD

Last Year

+21 807 000 USD

Current Quarter

+5 055 000 USD

Last Quarter

+5 586 000 USD
EBITDA -4 938 000 USD
Operating Margin TTM -1.72 %
Price to Earnings
Return On Assets TTM -9.54 %
PEG Ratio -0.44
Return On Equity TTM -106.93 %
Wall Street Target Price 2.00 USD
Revenue TTM 48 804 000 USD
Book Value 0.051 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 1.10 %
Dividend Yield
Gross Profit TTM 20 099 000 USD
Earnings per share -0.43 USD
Diluted Eps TTM -0.43 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -14.61 %

Stock Valuation IRIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.29
Price Sales TTM 0.44
Enterprise Value EBITDA -3.61
Price Book MRQ 19.71

Technical Indicators IRIX

For 52 Weeks

0.78 USD 2.14 USD
50 Day MA 1.00 USD
Shares Short Prior Month 329 224
200 Day MA 1.36 USD
Short Ratio 4.05
Shares Short 311 425
Short Percent 2.48 %